New Urine Test for Prostate Cancer - dailyRx

Press TV

New Urine Test for Prostate Cancer dailyRx Two molecules found in urine of prostate cancer patients were linked to the presence of aggressive cancer. Looking at levels of these biomarkers could eventually lead to the development of a third option for prostate cancer monitoring. Cleveland Clinic researcher: Proton beam therapy most costly, toxic common ...MedCity News all 9 news articles »

Precision Prostate Cancer Treatment - KMGH Denver

Precision Prostate Cancer Treatment KMGH Denver LOS ANGELES -- New treatments are helping men with prostate cancer live longer, but can still cause embarrassing side effects. Now, a new type of guided radiation is making life easier. Rick Dancer's life is a balancing act, he bounces his way through ... and more »

FDA Questions Benefit of Amgen Bone Drug in Certain Cases - Wall Street Journal (blog)

USA TODAY

FDA Questions Benefit of Amgen Bone Drug in Certain Cases Wall Street Journal (blog) Amgen conducted a study of Xgeva in 1432 men with prostate cancer that had not responded to previous therapies, but had not spread to the bones. Many types of cancer spread to the bones and cause tumors to grow, destroying the bone around the tumor, ... Benefit of Bone Drug in Prostate Cancer in DoubtMedPage Today FDA Staff Questions Merit of Expanding Use of Amgen's XgevaBusinessWeek FDA Skeptical of Amgen Drug Ahead of PanelTheStreet.com Bloomberg -DailyFinance all 219 news articles »

The Epigenetic promise for prostate cancer diagnosis - Abstract - UroToday

NY1

The Epigenetic promise for prostate cancer diagnosis - Abstract UroToday BACKGROUND: Prostate cancer is the most common cancer diagnosis in men and a leading cause of death. Improvements in disease management would have a significant impact and could be facilitated by the development of biomarkers, whether for diagnostic, ... PSA Testing's Next LeveldailyRx all 15 news articles »

Medivation prostate cancer drug well-tolerated in trial - Fox News

MD News

Medivation prostate cancer drug well-tolerated in trial Fox News Print Email Share Comments Recommend Tweet Medivation Inc's experimental prostate cancer pill caused fewer serious side effects in clinical trial patients than a placebo treatment, according to full results from a pivotal study announced on Tuesday. Extending Lives of Men With Prostate CancerdailyRx Drug Extends Survival in Patients with Drug-Resistant Prostate CancerHealthCanal.com all 90 news articles »